Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide)
Authors:
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 53 (3) , 567-575
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdownNeuropharmacology, 2008
- Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2‐arachidonylglycerolJournal of Neurochemistry, 2008
- RNA Interference-Mediated Knockdown of Dynamin 2 Reduces Endocannabinoid Uptake into Neuronal dCAD CellsMolecular Pharmacology, 2008
- Regional distribution and effects of postmortal delay on endocannabinoid content of the human brainNeuroscience, 2008
- Targeted lipidomics: Discovery of new fatty acyl amidesThe AAPS Journal, 2006
- An automated method for the analysis of stable isotope labeling data in proteomicsJournal of the American Society for Mass Spectrometry, 2005
- Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological FunctionBiochemical and Biophysical Research Communications, 1999
- Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratFEBS Letters, 1996
- Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- The Coördination of Silver Ion with Unsaturated CompoundsJournal of the American Chemical Society, 1938